Insights Directory



Showing 1-12 of 185 items

  • Taking the Pulse of Digital Assets: A Conversation with Joseph Vafi, CFA, CG’s Senior FinTech and Digital Assets Analyst

    Joseph Vafi, CFA, CG’s Senior Fintech and Digital Assets Analyst returns to the podcast with Michael Graham, Director of Research and Investment Strategy, following significant IPOs and policy updates in his space.

    Technology

    Listen to podcast

  • US Investment Banking Team Snapshot - Q2 2025

    Consumer and Retail

    Healthcare

    Sustainability

    Technology

    Download report

  • Software Quarterly Update - Q2 2025

    Technology

  • Vehicles and Autonomous Driving (Sustainability Part 1 of 2): A Conversation with George Gianarikas, CG's Sustainability Senior Analyst

    George Gianarikas, CG's Sustainability Senior Analyst, joins Michael Graham, Director of Research and Investment Strategy, to discuss the latest developments, challenges and opportunities for the EV and autonomous driving markets.

    Sustainability

    Listen to podcast

  • Technology, Media, Marketing, and Information Services - June 2025

    Technology

    Download report

  • US Technology Investment Banking Team Snapshot - Q2 2025

    Technology

    Download report

  • Cyber Security Quarterly Update - Q2 2025

    CG's Cyber Security Update for Q2 2025 provides an update on the current market landscape including valuation trends, and recent public and private transaction activity.

    Technology

  • NewSpace, Business in the Final Frontier: A Conversation with Austin Moeller, CG’s Aerospace and Defense Technology Analyst

    Austin Moeller, CG’s Senior Aerospace and Defense Technology Analyst, joins Michael Graham, Director of Research and Investment strategy to discuss the topical ideas in the space and travel markets.

    Industrials/Aerospace & Defense

    Listen to podcast

  • M&A Environment Report - Q2 2025

    Consumer and Retail

    Healthcare

    Sustainability

    Technology

  • Sustainability Dashboard - May 2025

    Sustainability

  • Navigating Nervous Times - The Risks, Rewards, and Complexities of Neurological Indications: A Conversation with Sumant Kulkarni CG’s Biotechnology Senior Analyst

    Sumant Kulkarni, CG’s Senior Analyst covering Biotechnology with a focus on neuroscience joins Director of Research and Investment Strategy Michael Graham, CFA to discuss the intricacies of indications in his space, the ever-present opportunities and how drug research and development have evolved over time. Listen here:

    Healthcare

    Listen to podcast

  • Digital Transformation Services Update - June 2025

    Technology

    Download report

By agreeing to save your details, your details will be stored in your browser for the duration of your session to make it simple to request additional reports.